Motor complications in Parkinson's disease (PD) are exacerbated by the pulsatile delivery of levodopa (L-DOPA). In this issue of Cell Host & Microbe, Padhi et al. engineer a microbiota-based therapeutic for sustained, non-fluctuating L-DOPA production, demons... ...

请注册登录后继续浏览